ProMIS Neurosciences Ownership 2024 | Who Owns ProMIS Neurosciences Now?
Institutional Ownership
2.50%
Insider Ownership
41.51%
Retail Ownership
55.99%
Institutional Holders
11.00
ProMIS Neurosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORTHEAST FINANCIAL CONSULTANTS INC | 1.33% | 0.03% | 100,000 | - | - | 473,000,000 | Mar 31, 2023 |
| IEQ CAPITAL, LLC | 0.52% | 0.00% | 39,191 | - | - | 185,373,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.20% | - | 14,715 | 1,566 | 11.91% | 69,602,000 | Mar 31, 2023 |
| CLARET ASSET MANAGEMENT CORP | 0.16% | 0.01% | 12,330 | - | - | 59,000 | Mar 31, 2023 |
| FIDUCIARY TRUST CO | 0.14% | 0.00% | 10,158 | - | - | 48,047,000 | Mar 31, 2023 |
| JPMORGAN CHASE & CO | 0.07% | - | 5,196 | -300 | -5.46% | 25,000,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.03% | - | 2,508 | -300 | -10.68% | 11,863,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.03% | - | 2,200 | -61 | -2.70% | 10,000,000 | Mar 31, 2023 |
| GABLES CAPITAL MANAGEMENT INC. | 0.01% | 0.00% | 833 | - | - | 3,940,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 333 | - | - | 1,564,000 | Mar 31, 2023 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 185 | - | - | 887,000 | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,344 | -100.00% | - | Mar 31, 2023 |
ProMIS Neurosciences's largest institutional shareholder is NORTHEAST FINANCIAL CONSULTANTS INC, holding 1.33% of the company's total share outstanding, currently valued at $473.00M. The top 10 institutional shareholders own together 2.50% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORTHEAST FINANCIAL CONSULTANTS INC | 1.33% | 0.03% | 100,000 | - | - | 473,000,000 | Mar 31, 2023 |
| CLARET ASSET MANAGEMENT CORP | 0.16% | 0.01% | 12,330 | - | - | 59,000 | Mar 31, 2023 |
| IEQ CAPITAL, LLC | 0.52% | 0.00% | 39,191 | - | - | 185,373,000 | Mar 31, 2023 |
| GABLES CAPITAL MANAGEMENT INC. | 0.01% | 0.00% | 833 | - | - | 3,940,000 | Mar 31, 2023 |
| FIDUCIARY TRUST CO | 0.14% | 0.00% | 10,158 | - | - | 48,047,000 | Mar 31, 2023 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 185 | - | - | 887,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.20% | - | 14,715 | 1,566 | 11.91% | 69,602,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 333 | - | - | 1,564,000 | Mar 31, 2023 |
| JPMORGAN CHASE & CO | 0.07% | - | 5,196 | -300 | -5.46% | 25,000,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.03% | - | 2,200 | -61 | -2.70% | 10,000,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.03% | - | 2,508 | -300 | -10.68% | 11,863,000 | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,344 | -100.00% | - | Mar 31, 2023 |
The largest ProMIS Neurosciences shareholder by % of total assets is NORTHEAST FINANCIAL CONSULTANTS INC. The company owns 100.00K shares of ProMIS Neurosciences (PMN), representing 0.03% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 0.20% | - | 14,715 | 1,566 | 11.91% | 69,602,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 333 | - | - | 1,564,000 | Mar 31, 2023 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 185 | - | - | 887,000 | Mar 31, 2023 |
| FIDUCIARY TRUST CO | 0.14% | 0.00% | 10,158 | - | - | 48,047,000 | Mar 31, 2023 |
| GABLES CAPITAL MANAGEMENT INC. | 0.01% | 0.00% | 833 | - | - | 3,940,000 | Mar 31, 2023 |
| IEQ CAPITAL, LLC | 0.52% | 0.00% | 39,191 | - | - | 185,373,000 | Mar 31, 2023 |
| CLARET ASSET MANAGEMENT CORP | 0.16% | 0.01% | 12,330 | - | - | 59,000 | Mar 31, 2023 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 1.33% | 0.03% | 100,000 | - | - | 473,000,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.03% | - | 2,200 | -61 | -2.70% | 10,000,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.03% | - | 2,508 | -300 | -10.68% | 11,863,000 | Mar 31, 2023 |
| JPMORGAN CHASE & CO | 0.07% | - | 5,196 | -300 | -5.46% | 25,000,000 | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,344 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, ProMIS Neurosciences's largest institutional buyer is BANK OF AMERICA CORP /DE/. The company purchased 1.57K stocks of PMN, valued at $69.60M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | - | - | - | -2,344 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | 0.07% | - | 5,196 | -300 | -5.46% | 25,000,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.03% | - | 2,508 | -300 | -10.68% | 11,863,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.03% | - | 2,200 | -61 | -2.70% | 10,000,000 | Mar 31, 2023 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 1.33% | 0.03% | 100,000 | - | - | 473,000,000 | Mar 31, 2023 |
| CLARET ASSET MANAGEMENT CORP | 0.16% | 0.01% | 12,330 | - | - | 59,000 | Mar 31, 2023 |
| IEQ CAPITAL, LLC | 0.52% | 0.00% | 39,191 | - | - | 185,373,000 | Mar 31, 2023 |
| GABLES CAPITAL MANAGEMENT INC. | 0.01% | 0.00% | 833 | - | - | 3,940,000 | Mar 31, 2023 |
| FIDUCIARY TRUST CO | 0.14% | 0.00% | 10,158 | - | - | 48,047,000 | Mar 31, 2023 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 185 | - | - | 887,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 333 | - | - | 1,564,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.20% | - | 14,715 | 1,566 | 11.91% | 69,602,000 | Mar 31, 2023 |
As of Mar 31 2023, ProMIS Neurosciences's biggest institutional seller is UBS GROUP AG. The company sold -2.34K shares of PMN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | - | - | - | -2,344 | -100.00% | - | Mar 31, 2023 |
ProMIS Neurosciences's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -2.34K shares, valued at -, as of undefined.
ProMIS Neurosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 2.06% | 1,075,686 | - | - | Mar 31, 2024 |
| SPARROW FUNDS | 0.65% | 2,305 | - | - | Feb 29, 2024 |
| TrimTabs ETF Trust | 0.02% | 16,351 | - | - | Jan 31, 2024 |
| Exchange Listed Funds Trust | 0.00% | 100 | - | - | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.00% | 63 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS 2 | 0.00% | 1,457 | - | - | Jan 31, 2024 |
ProMIS Neurosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 1.08M shares, compromising 2.06% of its total assets.
ProMIS Neurosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 11 | -8.33% |
| 31 Dec, 22 | 12 | 9.09% |
| 30 Sep, 22 | 11 | 1000.00% |
| 30 Jun, 22 | 1 | - |
As of 31 Mar 23, 11 institutions are holding ProMIS Neurosciences's shares, representing a decrease of -8.33% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 187,649 | -0.76% |
| 31 Dec, 22 | 189,088 | 2.30% |
| 30 Sep, 22 | 184,843 | 1748.43% |
| 30 Jun, 22 | 10,000 | - |
ProMIS Neurosciences (PMN) has 187.65K shares outstanding as of 31 Mar 23, down -0.76% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 2.50% | -4.82% |
| 31 Dec, 22 | 2.63% | 2.30% |
| 30 Sep, 22 | 2.57% | 1386.57% |
| 30 Jun, 22 | 0.17% | - |
As of 31 Mar 23, ProMIS Neurosciences is held by 2.50% institutional shareholders, representing a -4.82% negative growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | - |
| 31 Dec, 22 | 1 | - |
| 30 Sep, 22 | - | - |
| 30 Jun, 22 | - | - |
1 institutional shareholders have increased their position in PMN stock as of 31 Mar 23 compared to 1 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 3 | -25.00% |
| 31 Dec, 22 | 4 | - |
| 30 Sep, 22 | - | - |
| 30 Jun, 22 | - | - |
3 institutional shareholders have reduced their position in PMN stock as of 31 Mar 23 compared to 4 in the previous quarter (a -25.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 11 | -8.33% | 187,649 | -0.76% | 2.50% | -4.82% | 1 | - | 3 | -25.00% |
| 31 Dec, 22 | 12 | 9.09% | 189,088 | 2.30% | 2.63% | 2.30% | 1 | - | 4 | - |
| 30 Sep, 22 | 11 | 1000.00% | 184,843 | 1748.43% | 2.57% | 1386.57% | - | - | - | - |
| 30 Jun, 22 | 1 | - | 10,000 | - | 0.17% | - | - | - | - | - |
ProMIS Neurosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of ProMIS Neurosciences's stock was made by Title 19 Promis on Aug 02 2024, selling 500,000 shares at - per share (valued at -). The last insider buy of PMN was made by Kirwin Patrick D. on Aug 16 2024, buying 10,000 shares at $1.25 per share (worth $12.49K).
ProMIS Neurosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 17 | 3 | 566.67% |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 7 | 4 | 175.00% |
| Q3 2023 | 10 | 1 | 1000.00% |
| Q1 2023 | - | 5 | - |
| Q4 2022 | 11 | - | - |
| Q3 2022 | 3 | 30 | 10.00% |
| Q1 2021 | - | 3 | - |
| Q4 2019 | - | 1 | - |
| Q2 2019 | - | 1 | - |
| Q1 2019 | - | 3 | - |
| Q2 2018 | - | 1 | - |
| Q3 2017 | - | 2 | - |
| Q2 2003 | - | - | - |
17 total buy trades, and 3 total sell trades (buy/sell ratio of 5.67%) were made by ProMIS Neurosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 13 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 11 | - | - |
| Q3 2022 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q4 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q2 2018 | - | - | - |
| Q3 2017 | - | - | - |
| Q2 2003 | - | - | - |
As of Q3 2024, Insider owners conducted 13 open market buy trades and 0 open market sell trades of ProMIS Neurosciences's stocks.
ProMIS Neurosciences Peer Ownership
| Ticker | Company |
|---|---|
| CUE | Cue Biopharma, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| IVA | Inventiva S.A. |
| CNTA | Centessa Pharmaceuticals plc |
| HLVX | HilleVax, Inc. |
| STRO | Sutro Biopharma, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| GANX | Gain Therapeutics, Inc. |
| BIVI | BioVie Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| INAB | IN8bio, Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| OPT | Opthea Limited |
| CMPX | Compass Therapeutics, Inc. |
PMN Ownership FAQ
Who Owns ProMIS Neurosciences?
ProMIS Neurosciences is owned by institutional shareholders (2.50%), insiders (41.51%), and public (55.99%). The largest institutional shareholder of ProMIS Neurosciences is NORTHEAST FINANCIAL CONSULTANTS INC (1.33% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (2.06% of total shares).
Who are the major institutional shareholders of ProMIS Neurosciences?
ProMIS Neurosciences's major institutional shareholders are NORTHEAST FINANCIAL CONSULTANTS INC, IEQ CAPITAL, LLC, BANK OF AMERICA CORP /DE/, CLARET ASSET MANAGEMENT CORP, and FIDUCIARY TRUST CO. The top five shareholders own together 2.35% of the company's share outstanding.
How many ProMIS Neurosciences shareholders are there?
As of Mar 2023, there are 11 institutional shareholders of ProMIS Neurosciences.
What percentage of ProMIS Neurosciences is owned by NORTHEAST FINANCIAL CONSULTANTS INC?
NORTHEAST FINANCIAL CONSULTANTS INC owns 100K shares of ProMIS Neurosciences, representing 1.33% of the company's total shares outstanding, valued at $473M (as of Mar 2023).
What percentage of ProMIS Neurosciences is owned by IEQ CAPITAL, LLC?
As of Mar 2023, IEQ CAPITAL, LLC holds 39.19K shares of ProMIS Neurosciences (PMN), compromising 0.52% of the company, valued at $185.37M.
What percentage of ProMIS Neurosciences is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of ProMIS Neurosciences. The company owns 14.72K of the company's shares outstanding (worth $69.6M).